India News: An expert panel of the country’s central drug authority on Wednesday recommended against granting permission to the Serum Institute of India (SII) to

Govt panel recommends against allowing SII to conduct trial of Covovax on children aged 2-17 yrs

  • News
  • India News
  • Govt panel recommends against allowing SII to conduct trial of Covovax on children aged 2-17 yrs